At present, ChAc disease has no specific treatment, medications (such as dopamine blockers and VMAT2 inhibitors) can improve dyskinesia or rather chorea significantly, however not all of the symptoms of ChAc respond, and there may be side effects. The gene discussed is SLC18A2; the disease is drug-induced dyskinesia.